Iman Mohammadi, Ph.D.

Director, Research Science and Advanced Analytics

Iman Mohammadi, dressed in a dark pinstripe suit, white shirt, and navy tie, is smiling. He has short dark hair and stands before a blurred background with colorful vertical lines.

Iman leads, designs, and executes healthcare economics and advanced analytics projects and solutions. He conducts high-level analytic modeling to support health plan and life sciences organizations make optimal business decisions aimed at improving quality and lowering costs.

With experience in predictive modeling and advanced statistical techniques and a deep understanding of healthcare processes and challenges including market access, cardiology and oncology treatment patterns, real-word evidence generation, health economics and outcomes research, healthcare coverage models, and episode-based oncology care models, Iman provides insights, solutions, and decision-making tools for Inovalon customers.

Prior to joining Inovalon, Iman was a researcher and instructor at Indiana University. He focused on improving healthcare systems and patient centered outcomes research. Specifically, he used electronic health record data from various healthcare systems to develop predictive and simulation models for improving access to care for underserved populations. He taught undergrad and grad level courses, such as Informatics Project Management and Health Information Standards and Terminologies, at Indiana University.

Iman has a Ph.D. in health informatics from Indiana University and a Master of Biomedical Engineering from Purdue University.

Authored Content

Placeholder
Hematology, oncology

A Comparative Assessment of Travel Burden and Productivity Loss for CAR T-Cell Therapy and Bispecific Antibody Treatment in Patients With Relapsed/Refractory LBCL Using U.S. Claims Data

Accepted for presentation at International Society for Pharmacoeconomics and Outcomes Research. Findings available upon request. Contact us for more information.

Placeholder
Cardiovascular

Lipoprotein(a) Impact on Atherosclerotic Cardiovascular Disease and Major Adverse Limb Events Among Patients With Peripheral Artery Disease

Accepted for presentation at American College of Cardiology. Findings available upon request. Contact us for more information.

Placeholder
Oncology

The Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition

Accepted for presentation at International Society of Pharmacoeconomics and Outcomes Research Europe. Findings available upon request. Contact us for more information.

Placeholder
Cardiovascular

Impact of Elevated Lipoprotein(a) on Cardiovascular Events in Patients With Premature ASCVD: A Nationally Representative Sample of U.S. Medicare, Medicaid, and Commercial Enrollees

Accepted for presentation at American Heart Association. Findings available upon request. Contact us for more information.

A woman wearing glasses holds a tablet and stands in front of a large screen displaying rising bar chart values, suggesting a business presentation on real-world data in healthcare.
Life Sciences

Thriving in Uncertainty: How Real-World Data Powers Life Sciences Resilience

This white paper explores how life sciences can use real-world data to anticipate uncertainty, build resilience, and drive growth.

Read More →
Placeholder
Hematology, oncology

Treatment Patterns, Health Care Resource Utilization, and Costs of Chimeric Antigen Receptor T-cell vs. Standard Therapy for Relapsed/Refractory Mantle Cell Lymphoma in the United States

Real-world study of U.S. relapsed/refractory MCL patients compares CAR T-cell vs standard therapy. Shows longer treatment-free time & lower ongoing costs.

Read More →